The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study-Reference-Cited by-同舟云学术

The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study

Published:2018-11-22 Issue:1 Volume:6 Page:27-36
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Tremblay-Gravel Maxime¹,Marquis-Gravel Guillaume¹,Avram Robert¹,Desplantie Olivier¹,Ducharme Anique¹,Bibas Lior²,Pacheco Christine¹,Couture Etienne³,Simard François¹,Poulin Anthony⁴,Malhamé Isabelle²,Tran Dan⁴,Rey Evelyne⁵,Tournoux François⁶,Harvey Luc¹,Sénéchal Mario⁴,Bélisle Pierre⁷,Descarries Laurence⁸,Farand Paul³,Pranno Nicolas⁹,Diaz Ariel¹⁰,Afilalo Jonathan²,Ly Hung Q.¹,Fortier Annik¹¹,Jolicoeur Etienne Marc¹,

Affiliation:

1. Montreal Heart Institute; University of Montreal; Montreal Quebec Canada

2. McGill University; Montreal Canada

3. Centre Hospitalier Universitaire de Sherbrooke; University of Sherbrooke; Sherbrooke Canada

4. Institut Universitaire de Cardiologie et de Pneumologie de Québec; Laval University; Quebec City Canada

5. Hôpital Sainte-Justine; University of Montreal; Montreal Canada

6. Centre Hospitalier Universitaire de Montréal; University of Montreal; Montreal Canada

7. Hôpital de Chicoutimi; University of Sherbrooke; Saguenay Canada

8. Hôpital de la Cité-de-la-Santé; University of Montreal; Laval Canada

9. Hôpital Maisonneuve-Rosemont; University of Montreal; Montreal Canada

10. Centre Hospitalier Affilié Universitaire Régional de Trois-Rivières; University of Montreal; Trois-Rivières Canada

11. Montreal Health Innovations Coordinating Center; University of Montreal; Montreal Canada

Funder

Montreal Heart Institute Research Center

Canadian Cardiovascular Society and Bayer Resident Vascular Award

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12376/fullpdf

Reference20 articles.

1. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy;Hilfiker-Kleiner;Cell,2007

2. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy;Patten;Nature,2012

3. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy;Sliwa;Eur J Heart Fail,2010

4. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study;Sliwa;Circulation,2010

5. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-associated Cardiomyopathy);McNamara;J Am Coll Cardiol,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripartumkardiomyopathie;Springer Reference Medizin;2024

2. Bromocriptine: does this drug of Parkinson’s Disease have a role in managing cardiovascular diseases?;Annals of Medicine & Surgery;2023-12-20

3. Proteomic Signatures of Peripartum Cardiomyopathy;JACC: Heart Failure;2023-12

4. Cardio-Obstetrics and Heart Failure;JACC: Heart Failure;2023-09

5. Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects;International Journal of Molecular Sciences;2023-08-26